ARTICLE | Company News
Cardiovascular markers deal
March 1, 2000 8:00 AM UTC
Axis-Shield (LSE:ASD, Dundee, U.K.) granted Bayer (Pittsburgh, Penn.) a license to commercialize its Activated Factor XII (AFT or XIIa) and homocysteine cardiovascular disease markers. The markers wil...